"It would be a fruitless enterprise," Owsei Temkin wrote in 1964, "to enter upon speculations on the origins of drug therapy. Suffice to say that it is very old." All the same, modernists like to think of the practice of clinical trials for drug therapy as a relatively new thing in the world. Many of my clinical colleagues consider the randomized controlled trial (RCT) the central element in modern medical epistemology, a "gold standard" that neatly divides the evidence-based medicine of the present from the evidence-free medicine of the premodern past. Coming to terms with the clinical trial as an older form of medical evidence, with roots in princely politics and prisoner pardons, is a more challenging task. Likewise, historians of science often leave medicine out of the broader history of experiment. In spite of the efforts of a number of scholars to locate medicine as a central site for the development of empirical and experimental knowledge in the medieval and early modern period, it has been far too easy for historians to casually refer to the incorporation of experiment into medicine as something that develops only in the nineteenth and twentieth centuries. As the editors of this special issue of the Bulletin of the History of Medicine point out, this omission occurs because drug testing has remained a relatively understudied area among historians of medieval and early modern medicine. In directly challenging both of these assumptions, the articles of this volume constitute a powerful and important intervention that demonstrates the direct relevance of early modern European history of pharmacy and therapeutics to present-day practitioners as well as historians of science, medicine, and technology. True, the methodology of the trials they document might not pass muster with a twenty-first-century Institutional Review Board, a National Institutes of Health study section, or the editorial board of The Lancet, but the forms traced in these essays bear enough genealogical similarities to present-day therapeutic proofs to be sufficiently unsettling. At the very least, they give the lie to the casual assumption that the modern form of therapeutic proof was simply the intellectual accomplishment of Austin Bradford Hill in his MRC offices in 1948. Rather, the reader of this volume finds that the things we do for proof today have roots that stretch back centuries and are as steeped in the social relations of state power, the role of expert knowledge in the bureaucratic systems, and the marketing strategies of drug manufacturers as they are in any purity of method or philosophical principle. One comes away from this collection of articles with a greater awareness of the cracks in the edifice of therapeutic truth-making that twenty-first-century pharmaceutical manufacturers, physicians, and patients have come to inhabit. The period, place, actors, and scope of action in these contributions range widely, from Michael McVaugh's opening article on experimental protocols for drug provings among the fourteenth-century medical faculty of Montpellier to the eighteenth-century attempt to understand and replicate the blood miracle of St. Januarius, chronicled in Francesco Paolo de Ceglia's concluding essay. The drugs tested vary from bath waters to the blood of saints, from pancreatic extracts to whole chickens; the sites of analysis range across French and German courts, learned societies, hospitals, pharmacies, and households; and the actors cross in and out of learned societies, academic institutions, state regulators, and orthodox medical professionals. And yet the contributions of all scholars cohere around several points of continued interest to therapeutic practice and experimental proof today: the relation of reason, rationality, and experiment; the problem of designating on whose bodies such proofs should be tested; and the broader social role that methods for designating legitimate from illegitimate cures play in the relation of the medical profession and the regulatory state in shaping markets and monopolies for medical practice and pharmaceutical manufacture.
...More
Article
Donald Gillies;
(2017)
Evidence of mechanism in the evaluation of streptomycin and thalidomide
(/isis/citation/CBB434797387/)
Article
Justin Rivest;
(2017)
Testing Drugs and Attesting Cures: Pharmaceutical Monopolies and Military Contracts in Eighteenth-Century France
(/isis/citation/CBB955037337/)
Article
Simon, Jonathan;
(2007)
The Origin of the Production of Diphtheria Antitoxin in France, between Philanthropy and Commerce
(/isis/citation/CBB000820146/)
Article
Yang, Timothy;
(2012)
Selling an Imperial Dream: Japanese Pharmaceuticals, National Power, and the Science of Quinine Self-Sufficiency
(/isis/citation/CBB001231668/)
Book
Kathryn T. Hall;
(2022)
Placebos
(/isis/citation/CBB774087923/)
Book
Matthew James Crawford;
Joseph M. Gabriel;
(2019)
Drugs on the Page: Pharmacopoeias and Healing Knowledge in the Early Modern Atlantic World
(/isis/citation/CBB528992656/)
Article
María González-Moreno;
Cristian Saborido;
David Teira;
(2015)
Disease-mongering through clinical trials
(/isis/citation/CBB362630000/)
Thesis
Fisher, Jill A.;
(2005)
Pharmaceutical Paternalism and the Privatization of Clinical Trials
(/isis/citation/CBB001561585/)
Book
Carla Camana;
Ernesto Riva;
(2017)
le farmacopee private in Europa dalle origini ai tempi moderni
(/isis/citation/CBB412027120/)
Book
Fisher, Jill;
(2009)
Medical Research for Hire: The Political Economy of Pharmaceutical Clinical Trials
(/isis/citation/CBB000953570/)
Book
Frederick W. Gibbs;
(2018)
Poison, Medicine, and Disease in Late Medieval and Early Modern Europe
(/isis/citation/CBB877960706/)
Article
Elaine Leong;
Alisha Rankin;
(2017)
Testing Drugs and Trying Cures: Experiment and Medicine in Medieval and Early Modern Europe
(/isis/citation/CBB492340232/)
Book
Gaudillière, Jean-Paul;
Hess, Volker;
(2008)
Ways of Regulating: Therapeutic Agents between Plants, Shops and Consulting Rooms
(/isis/citation/CBB001221032/)
Article
Daemmrich, Arthur;
Bowden, Mary Ellen;
(2005)
A Rising Drug Industry: Pharmaceuticals since 1870
(/isis/citation/CBB001221029/)
Article
Rodríguez Nozal, Raúl;
(2007)
Sanidad, farmacia y medicamento industrial durante la II República (1931--1936)
(/isis/citation/CBB000930338/)
Book
Nancy D. Campbell;
(2020)
OD: Naloxone and the Politics of Overdose
(/isis/citation/CBB601007525/)
Article
Abraham, John;
Davis, Courtney;
(2006)
Testing Times: The Emergence of the Practolol Disaster and Its Challenge to British Drug Regulation in the Modern Period
(/isis/citation/CBB000770617/)
Article
Sihn, Kyu-hwan;
(2013)
The Institutionalization of Pharmaceutical Administration after the Korean Liberation: Focusing on Regulating the Pharmaceutical Affairs Law (Yaksabeop) in 1953
(/isis/citation/CBB001214039/)
Chapter
Hess, Volker;
(2008)
Secrets, Bureaucracy and the Public Drug Regulation in Prussia of the Early 19th Century
(/isis/citation/CBB001221034/)
Book
Lucas Richert;
(2014)
Conservatism, Consumer Choice, and the Food and Drug Administration During the Reagan Era: A Prescription for Scandal
(/isis/citation/CBB836915571/)
Be the first to comment!